Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/E ratio high or low?
The P/E ratio of 9.07 is 87% below its 5-year average of 68.69, near the low end of its 5-year range (9.04–79.45).
As of 2026-10-06T15:10:45.700Z. 3.59% below its 12-month average of 9.41.
Calculation as of: 2026-10-06T15:10:45.700Z.
Quote observation: 2026-10-06T15:10:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c282ae091baa43953544eb6230b380cd5117f3a7263491550c34677a7a4faed2
PE Ratio (9.07) = Close Price ($48.72) / Diluted TTM EPS ($5.37)
PE RATIO
9.07
PE RATIO AVG TTM
9.41
PE RATIO AVG 3Y
9.41
PE RATIO AVG 5Y
68.69
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.59%
CURRENT VS 3Y AVG
-3.59%
CURRENT VS 5Y AVG
-86.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
25.37
median of 164 covered companies
CURRENT VS SECTOR MEDIAN
-64.25%
vs the sector median at left
Market Cap
$1.46B
PE Ratio
12.45
TTM Avg
30.95
3Y Avg
30.73
5Y Avg
31.04
Market Cap
$1.50B
PE Ratio
15.19
TTM Avg
21.09
3Y Avg
55.49
5Y Avg
39.46
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AnaptysBio, Inc. (ANAB) | $1.44B | 9.07 | 9.41 | 9.41 | 68.69 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 12.45 | 30.95 | 30.73 | 31.04 |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.47B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.41B | N/A | 0.13 | 0.13 | 0.13 |
| Certara, Inc. (CERT)vs › | $1.48B | N/A | 174.30 | 183.89 | 183.89 |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 15.19 | 21.09 | 55.49 | 39.46 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 143.60 | 152.77 | 83.75 | 83.75 |
At 9.1, P/E is below its 5-year median — higher than 2% of readings in its 5-year history.
5-year low
9.0
median
66.6
5-year high
79.5
Trailing P/E
9.1
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$48.72
Forward EPS (Est.)
$-2.28
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-10-05 | 9.16 |
| 2026-10-02 | 9.04 |
| 2026-10-01 | 9.06 |
| 2026-09-30 | 9.36 |
| 2026-09-29 | 9.38 |
| 2026-09-28 | 9.46 |
| 2026-09-25 | 9.50 |
| 2026-09-24 | 9.63 |
| 2026-09-23 | 9.45 |
| 2026-09-22 | 10.04 |
| 2022-03-07 | 63.63 |
| 2022-03-04 | 64.17 |
| 2022-03-03 | 63.54 |
| 2022-03-02 | 65.19 |
| 2022-03-01 | 64.17 |
| 2022-02-28 | 64.84 |
| 2022-02-25 | 66.66 |
| 2022-02-24 | 67.29 |
| 2022-02-23 | 63.47 |
| 2022-02-22 | 64.75 |
| 2022-02-18 | 63.63 |
| 2022-02-17 | 63.47 |
| 2022-02-16 | 65.51 |
| 2022-02-15 | 66.56 |
| 2022-02-14 | 64.56 |
| 2022-02-11 | 63.60 |
| 2022-02-10 | 64.56 |
| 2022-02-09 | 68.63 |
| 2022-02-08 | 66.08 |
| 2022-02-07 | 67.29 |
| 2022-02-04 | 66.53 |
| 2022-02-03 | 63.82 |
| 2022-02-02 | 66.02 |
| 2022-02-01 | 67.61 |
| 2022-01-31 | 67.80 |
| 2022-01-28 | 66.34 |
| 2022-01-27 | 63.60 |
| 2022-01-26 | 66.62 |
| 2022-01-25 | 68.95 |
| 2022-01-24 | 68.88 |
| 2022-01-21 | 65.73 |
| 2022-01-20 | 65.99 |
| 2022-01-19 | 68.37 |
| 2022-01-18 | 68.41 |
| 2022-01-14 | 71.56 |
| 2022-01-13 | 69.42 |
| 2022-01-12 | 73.72 |
| 2022-01-11 | 74.67 |
| 2022-01-10 | 71.91 |
| 2022-01-07 | 69.49 |
| 2022-01-06 | 71.75 |
| 2022-01-05 | 69.58 |
| 2022-01-04 | 74.77 |
| 2022-01-03 | 76.23 |
| 2021-12-31 | 73.72 |
| 2021-12-30 | 74.90 |
| 2021-12-29 | 74.58 |
| 2021-12-28 | 76.20 |
| 2021-12-27 | 77.41 |
| 2021-12-23 | 78.62 |
| 2021-12-22 | 76.96 |
| 2021-12-21 | 75.85 |
| 2021-12-20 | 76.71 |
| 2021-12-17 | 75.44 |
| 2021-12-16 | 74.90 |
| 2021-12-15 | 73.75 |
| 2021-12-14 | 66.56 |
| 2021-12-13 | 66.21 |
| 2021-12-10 | 63.63 |
| 2021-12-09 | 63.63 |
| 2021-12-08 | 66.34 |
| 2021-12-07 | 65.89 |
| 2021-12-06 | 64.97 |
| 2021-12-03 | 64.05 |
| 2021-12-02 | 67.17 |
| 2021-12-01 | 66.21 |
| 2021-11-30 | 68.63 |
| 2021-11-29 | 65.00 |
| 2021-11-26 | 66.02 |
| 2021-11-24 | 67.45 |
| 2021-11-23 | 66.47 |
| 2021-11-22 | 65.19 |
| 2021-11-19 | 65.32 |
| 2021-11-18 | 66.97 |
| 2021-11-17 | 67.39 |
| 2021-11-16 | 67.42 |
| 2021-11-15 | 68.18 |
| 2021-11-12 | 69.46 |
| 2021-11-11 | 70.54 |
| 2021-11-10 | 71.97 |
| 2021-11-09 | 74.23 |
| 2021-11-08 | 79.45 |
| 2021-11-05 | 78.62 |
